The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
Christopher G. Davey(The University of Melbourne), Patrick D. McGorry(Orygen Youth Health), Sue Cotton(Monash University), Danijela Piškulić(The University of Melbourne), Aswin Ratheesh(The University of Melbourne), Melissa Kerr(The University of Melbourne), Olivia Dean(Antwerp University Hospital), Andrew M. Chanen(Orygen Youth Health), Alexandra Parker(The University of Melbourne), Mark Phelan(Orygen), G. Paul Amminger(The University of Melbourne), Susy Harrigan(Orygen Youth Health), Sarah Hetrick(University of Auckland), Michael Berk(The Royal Melbourne Hospital), Miriam R. Schäfer(Medical University of Vienna), Andrew Mackinnon(Black Dog Institute), Kally Yuen(Princess Margaret Cancer Centre), Ben J. Harrison(The University of Melbourne)
Cited by 12
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
|The Lancet Psychiatry|2019|1.5k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806